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Abstract
The United Nations (UN) issued official probabilistic population projections for all coun-
tries to 2100 in July 2015. This was done by simulating future levels of total fertility and
life expectancy from Bayesian hierarchical models, and combining the results using a stan-
dard cohort-component projection method. The 40 countries with generalized HIV/AIDS
epidemics were treated differently from others, in that the projections used the highly mul-
tistate Spectrum/EPP model, a complex 15-compartment model that was designed for
short-term projections of quantities relevant to policy for the epidemic. Here we propose
a simpler approach that is more compatible with the existing UN probabilistic projection
methodology for other countries. Changes in life expectancy are projected probabilisti-
cally using a simple time series regression model on current life expectancy, HIV prevalence
and ART coverage. These are then converted to age- and sex-specific mortality rates using
a new family of model life tables designed for countries with HIV/AIDS epidemics that
reproduces the characteristic hump in middle adult mortality. These are then input to the
standard cohort-component method, as for other countries. The method performed well
in an out-of-sample cross-validation experiment. It gives similar population projections
to Spectrum/EPP in the short run, while being simpler and avoiding multistate modeling.
Keywords: Bayesian hierarchical model, Cohort-component projection method, Esti-
mation and Projection Package, Mortality, Multistate model, Model life table, Spectrum,
UNAIDS, World Population Prospects
1 Introduction
Population projections are used by governments at all levels, international organizations,
social and health researchers, and by the private sector for policy planning, monitoring
development goals and as inputs to economic and environmental models. The United
Nations (UN) issues population projections for all the countries of the world by age and
sex to 2100, updated every two years, in the World Population Prospects (WPP). It is
the only organization to do so, and its projections are the de facto standard at the global
level (Lutz and Samir 2010).
There has long been great interest in probabilistic population projections, to quan-
tify uncertainty in projections and the risk of adverse demographic events. However,
the dominant population projection methods are deterministic, and uncertainty has typ-
ically been conveyed by variant scenario projections (such as High and Low projections)
using different assumptions about future rates. This approach has been criticized as lack-
ing validity because it has no probabilistic basis, and leads to possible contradictions
(Lee and Tuljapurkar 1994; National Research Council 2000).
In a major step forward, the UN issued official probabilistic population projections for
all countries in July 2015, available at http://esa.un.org/unpd/ppp. These projections
were developed using the methodology of Raftery et al. (2012). They take account of
uncertainty about future levels of total fertility and life expectancy, using the Bayesian
hierarchical models of Alkema et al. (2011) for fertility and Raftery et al. (2013) for life
expectancy. Between-country correlation in fertility rates is accounted for by the method
of Fosdick and Raftery (2014), and correlation between male and female life expectancy
is modeled by the method of Raftery et al. (2014).
These statistical models allow a large number of trajectories of future fertility and mor-
tality for all countries to be simulated from their predictive probability distributions. Each
simulated trajectory of future life expectancy is converted to age-specific mortality rates
using a modified Lee-Carter method (Li and Gerland 2011; Li et al. 2013; Raftery et al.
2012; Sˇevcˇ´ıkova´ et al. 2016a). Future age-specific fertility and mortality rates are then
converted to future population by age and sex by the standard cohort-component method
(Preston et al. 2001; Whelpton 1936), using the bayesPop R package (Sˇevcˇ´ıkova´ et al.
2016b). The result is a sample of possible future trajectories of world population by
country, age and sex, to 2100. It can be viewed as a large number of possible versions of
the 2100 revision of the UN’s World Population Prospects (which won’t exist for another
84 years).
The UN’s new probabilisticWorld Population Prospects currently treats countries with
generalized HIV/AIDS epidemics (defined as having had HIV prevalence greater than 2%
at any time since 1980, and hereafter referred to as the “AIDS countries”) differently
from others. These countries have very different mortality patterns compared to countries
without generalized HIV epidemics, with a large mortality hump in middle adulthood due
to AIDS, and so they cannot be modeled using, for example, standard model life tables.
The UN’s current method for probabilistically projecting mortality for these countries
starts with the deterministic projection from the 2015 revision of the World Population
Prospects (United Nations 2015b). This uses the Spectrum model developed for UNAIDS
(Futures Institute 2016; Stanecki et al. 2012; Stover et al. 2012), a complex multistate
model that divides adults into 15 compartments according to their HIV status, and models
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transitions among these 15 compartments. In a second stage, the Bayesian hierarchical
model of Raftery et al. (2013) for life expectancy and the modified Lee-Carter method
are applied to all countries, including the AIDS countries, yielding simulated age- and
sex-specific mortality rates. In a third and final stage, the predictive distribution of each
future age- and sex-specific mortality rate is adjusted so that its median coincides with
the deterministic projection from the first stage.
This method has several limitations. It relies on the Spectrum multistate model, which
was developed primarily to answer short-term policy questions about the AIDS epidemic,
such as future need for antiretroviral therapy (ART) drugs, the number of AIDS orphans,
and so on. Because of its complexity and reliance on a large number of assumptions about
transition rates between the many compartments, it was not designed for medium and
long-term projections. Indeed the UNAIDS Reference Group on Estimation, Projection
and Modelling notes that Spectrum projections more than five years into the future are
unreliable (UNAIDS 2015, p. 9).
The UN Population Division (UNPD) has very different needs. It provides projections
of population that are long-term, to 2100, but output only overall population and vital
rates, and so do not need the level of detail in Spectrum. The need to use a different
methodology for a subset of countries (about 20% of the world’s countries) is also a
difficulty.
Here we propose an alternative methodology for probabilistic projection for the AIDS
countries that is simpler than the current one, does not require any multistate model-
ing, and makes use of the bayesPop methodology used by the UN for other countries.
It requires probabilistic projections of overall HIV prevalence, and these are obtained
from the relatively simple non-age-structured Estimation and Projection Package (EPP)
(Brown et al. 2010; Ghys et al. 2004; Ghys and Garnett 2010; Ghys et al. 2008). Future
life expectancy is projected using a simple time series regression model on HIV preva-
lence and ART coverage. The resulting simulated life expectancies and prevalences are
converted to age-specific mortality rates using the HIV prevalence-calibrated model life
table method of Sharrow et al. (2014), which replicates the middle adult mortality hump
characteristic of HIV epidemics. The population projections are then obtained with the
same bayesPop methodology as for other countries.
The resulting method fits observed age-specific mortality data well. In an out-of-
sample validation experiment it was reasonably accurate and provided well-calibrated
probabilistic projections of aggregate mortality and population quantities. It is simpler
than the extant Spectrum method, but still matched its projections closely over the next
15 years. This suggests that this method may be appropriate for probabilistic population
projection for AIDS countries.
The rest of the article is organized as follows. In Section 2 we describe our new methods
and the data we use. In Section 3 we give results for four countries with generalized
HIV/AIDS epidemics, chosen to represent the range of experience, namely Botswana,
Zimbabwe, Mozambique and Sierra Leone. Then in Section 4 we give the results of
an out-of-sample validation experiment to assess our method, and we also compare the
resulting projections with those of Spectrum. We conclude in Section 5 with a discussion
of the strengths and limitations of our proposed approach.
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2 Methods and Data
Population projection involves combining future values of age-specific fertility, age- and
sex-specific mortality, and international migration rates, in this case using the standard
cohort component model. To make probabilistic projections for high-HIV prevalence coun-
ties, we follow the procedure described by Raftery et al. (2012) for making probabilistic
projections of fertility in countries without generalized HIV/AIDS epidemics and use the
UNPD assumptions about international migration (United Nations 2015a, p. 30-31), but
we modify the mortality component to account for HIV/AIDS mortality.
Raftery et al. (2012) simulate a large number of trajectories of the Total Fertility
Rate (TFR) using the Bayesian hierarchical model of Alkema et al. (2011). The projected
TFRs are then converted to age-specific rates using model fertility patterns. For mortality,
Raftery et al. (2012) simulate an equal number of trajectories of period life expectancy at
birth (e0) for females using the model of Raftery et al. (2013). Male life expectancies are
conditional on the female e0 and are derived from a model that predicts the gap in male
and female e0 (Raftery et al. 2014). These e0 projections are converted to age-specific
mortality rates using a variant of the Lee-Carter method (Li et al. 2013; Sˇevcˇ´ıkova´ et al.
2016a). The fertility, mortality, and migration trajectories are then converted to a future
trajectory of age- and sex-specific population values using the cohort component method
(Preston et al. 2001, ch. 6).
In our application, the projection of fertility remains the same1 along with the use of
the UNPD assumptions about international migration and the cohort component method
to combine these trajectories. A brief description of the methods for projecting e0 and
HIV prevalence as well as converting those quantities into age-specific mortality rates
follows.
2.1 Projecting HIV prevalence
To make probabilistic projections of e0 for countries with generalized epidemics and to
convert those projections into age-specific mortality rates, we first need projections of HIV
prevalence. We use a version of the UNAIDS Estimation and Projection Package (EPP)
(Alkema et al. 2007; Brown et al. 2010; Ghys and Garnett 2010; Raftery and Bao 2010)
for the statistical analysis software R to make probabilistic projections of HIV prevalence
up to 2100.
EPP works well to project HIV prevalence into the not too distant future, approxi-
mately 5-10 years after the latest surveillance (UNAIDS 2015), but assumptions mirroring
those made by UNPD in the WPP 2010 revision were imposed on two of the EPP model
parameters to make projections to 2100 (United Nations 2011). For most countries, the
model is fitted assuming that the relevant parameters have remained constant in the past.
Beginning in the start year of the projection, the parameter φ, which reflects the rate of
recruitment of new individuals into the high-risk or susceptible group, is projected to
decline by half every 20 years. The parameter r, which represents the force of infection,
is projected to decline by half every 30 years. The reduction in r reflects the assumption
1 Fertility is projected using the bayesTFR package (Sˇevcˇ´ıkova´ et al. 2011) in the statistical analysis
software, R.
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that changes in behavior among those subject to the risk of infection and increases in
access to treatment for infected individuals will reduce the chances of HIV transmission.
Then, we define the median HIV prevalence trajectory to 2100 for each country as that
projected by UNAIDS and generate 1,000 trajectories from EPP to define uncertainty
about that. Let zc,t be the HIV prevalence in country c at time t from the single UNAIDS
trajectory. Let zkc,t be the prevalence in country c at time t for trajectory k output from
EPP, k = 1, . . . , 1000. We create 1,000 new trajectories by multiplying the UNAIDS
trajectory by scalars of the form
zkc,t
zc,t
. We compute five-year averages from the new yearly
trajectories to be used in the projection of female life expectancy.
2.2 Projecting life expectancy at birth, e0
Because a generalized HIV epidemic can have a considerable depressing effect on life
expectancy at birth in a short time (Blacker 2004; Bor et al. 2013; Ngom and Clark
2003; Obermeyer et al. 2010; Poit et al. 2001; Reniers et al. 2014; Sharrow et al. 2013;
Timaeus and Jasseh 2004), a model that reflects the impact of HIV prevalence and an-
tiretroviral therapy (ART) coverage is necessary to make appropriate projections of e0
in generalized epidemics. Let HIVc,t and ARTc,t be the HIV prevalence and adult
ART coverage in country c at time t, respectively. Then, HIV nonART (HnA)c,t =
HIVc,t × (100 − ARTc,t), so that HnAc,t represents the percentage of infected people
not receiving ART in country c at time t. The model for projecting e0, Eq. 1, predicts
the five-year increase in female life expectancy at birth from time t− 5 to t as
∆e0,c,(t−5:t) = g(e0,c,t−5|θ
(c)) + βHnA∆HnAc,t−5 + εc,t−5 (1)
where ∆e0,c,(t−5:t) is the change in life expectancy for country c at time t − 5 to t,
g(e0,c,t−5|θ
(c)) is the double logistic fitted change in life expectancy at time t − 5 to t
given life expectancy at time t− 5, and εc,t−5 is the error term. We construct a Bayesian
hierarchical model by placing priors on all parameters in the model. (See Raftery et al.
(2013) for details.)
The double logistic term is the same as the model used for countries not substan-
tially impacted by HIV/AIDS (Raftery et al. 2013) and reflects the transition from high
to low mortality, which can be broken down into two processes, each represented by a
single logistic function. The first process describes initial slow growth in e0 with small
improvements in mortality at low levels of e0 resulting from gains in hygiene and nutrition
followed by a quicker pace of improvement, and the second represents continuing gains
from combating non-communicable diseases (Omran 2005; United Nations 2015a).
The Bayesian hierarchical model (Eq. 1) is estimated via Markov chain Monte Carlo
simulation. For our observed data we use five-year female life expectancy estimates from
1950-2015 for all 201 countries from the WPP 2015 (United Nations 2015b). We use
the single UNAIDS trajectory of HIV prevalence to construct five-year averages for 1950-
2015. We use a single trajectory of ART coverage (percentage of seropositive individuals
receiving ART) for the periods 1950-2100 for each country obtained from UNPD internal
tabulations (United Nations 2011). Note that countries not experiencing a generalized
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epidemic have HnA values of 0 for all time periods. To project female life expectancy
to 2100, we input each trajectory of HnA and life expectancy period by period into the
model starting from 2015, drawing random perturbations, εc,t, from a zero-mean Gaussian
distribution whose variance is a function of life expectancy at time t for each five-year time
period. Countries with a generalized HIV/AIDS epidemic have more intrinsic variability
than those without. Therefore, HIV/AIDS countries draw random perturbations from a
distribution with larger variance than those not experiencing an epidemic. The process
for deriving sex- and age-specific mortality rates from the projected female e0 is described
in the following section.
2.3 Converting e0 and HIV prevalence projections to age-specific mortal-
ity rates
Once we have obtained probabilistic projections of HIV prevalence and female life ex-
pectancy, we need to map those quantities onto a sets of sex- and age-specific mortality
rates that can be combined with age-specific fertility rates and net migration using the
cohort component method. In the WPP 2015 Revision for countries without high HIV
prevalence, age-specific mortality rates are either extrapolated from recent data if they
are available or obtained by converting e0 projections to age-specific mortality rates using
model mortality patterns (United Nations 2015a, p. 27-28), but recent data are typi-
cally unavailable in this region of the world and model mortality patterns are unable
to replicate the particular age pattern of mortality resulting from large scale HIV epi-
demics (United Nations 2015a, p. 28). Available model mortality patterns also have no
relationship to HIV prevalence.
To convert the female life expectancy and HIV prevalence projections to sex- and
age-specific mortality rates we use the model of Sharrow et al. (2014), shown in Eq. 2.
This model can reproduce the characteristic age pattern of mortality associated with
generalized epidemics, i.e. an accentuated adult mortality hump concentrated at ages 30
to 45. The model represents the age pattern of mortality rates as a weighted sum of three
age-varying components. The components, bi,x in Eq. 2, are derived from a Singular
Value Decomposition (SVD) of the matrix of observed historical mortality rates and the
weights, ωi,ℓ, are modeled as a function of HIV prevalence and female life expectancy at
birth. As described in Sharrow et al. (2014), HIV MLT is not currently calibrated with
ART coverage because there is not sufficient variation in country-level ART coverage for
it to be a significant predictor of the weights in Eq. 2. However, we have included the
effect of ART in the life expectancy projection, and as ART coverage nears universal
levels in the future, the observed calibration data will likely include sufficient variation
in ART coverage to be included in future iterations of this method. Importantly, the
SVD is performed on a matrix that keeps the male and female mortality rates for a given
country and period together such that the bi,x are vectors of length 44 (two times the
number of age groups). This step allows us to generate male and female mortality rates
simultaneously as a function of female e0 and HIV prevalence. Because the age-varying
components, bi,x are fixed, the component weights, ωi,ℓ, which are modeled as a function
of HIV prevalence and e0, are the effective parameters in this model. We refer to this
model as “HIV MLT,” for “HIV-calibrated model life table.” The model is defined as
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follows:
ln(mx,ℓ) = cℓ +
3∑
i=1
ωi,ℓbi,x + εx,ℓ, (2)
where mx,ℓ is the period age-specific mortality rate for age x in life table ℓ, cℓ is a constant
specific to life table ℓ, bi,x is the value of the ith component for age x, ωi,ℓ is the weight
of the ith component for life table ℓ, and εx,ℓ
iid
∼ N(0, σ2) is the error term.
Figure 1 plots the fit from the HIV MLT model and four existing model life table
systems for South Africa females 2010-2015. HIV prevalence has remained high in South
Africa and was roughly 17.4% during this period, resulting in a large adult mortality
hump. Figure 1 demonstrates how this pattern is fully captured only by the HIV MLT
model. All other systems tend to produce patterns of mortality rates that match the
overall level of mortality as measured by period life expectancy at birth but miss the
age-specific rates, which are critical for accurate population projection.
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Figure 1 Output from HIV MLT model. (a) Fit of HIV MLT model for
South Africa females 2010-2015. HIV MLT model shown with black line.
For comparison, fits from the WHO modified logit model (Murray et al. 2003)
[red solid line], Coale and Demeny model life tables (Coale and Demeny 1966;
Coale et al. 1983) [green solid line], UN model life tables for developing countries
(United Nations. Department of International Economic and Social Affairs 1982) [teal
solid line], and the Log-Quad model (Wilmoth et al. 2012) [purple solid line] are also
shown. (b) Sex-specific output e0, varying the two HIV MLT model inputs: female e0
and HIV prevalence.
This model takes e0 and HIV prevalence as inputs and produces a set of age-specific
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mortality rates that reflect those two inputs.2 HIV MLT is designed to produce a set
of age-specific mortality rates that yield an output life expectancy matching the in-
put life expectancy. The HIV MLT model was originally calibrated with sex-specific
e0 (Sharrow et al. 2014), but for the present purpose we have re-calibrated the model
with the female e0 because that is what is projected by the model described in section
2.2. To maintain the gap between male and female e0, the re-calibrated HIV MLT model
produces complete sets of male and female age-specific mortality rates simultaneously
and matches the input e0 to the female life expectancy derived from the output female
mortality rates by adjusting the intercept, cℓ in Eq. 2. The male rates are adjusted using
the same adjusted intercept used to match female e0. Figure 1b plots the sex-specific
output e0 from the HIV MLT model while varying the two input parameters: female e0
and HIV prevalence. The gap in life expectancy is maintained over all combinations of
the two input parameters. The female output e0 equals the input e0 and the male output
e0 is always below the output female e0.
The HIV MLT model is calibrated with five-year age-specific mortality rates obtained
from WPP 2015 from 1970-2015 for the 40 countries experiencing a generalized epidemic.
HIV prevalence for calibrating this model is the same as for the model for projecting e0
(see Section 2.2). To produce a draw from the predictive distribution of the vector of
age-specific mortality rates, a sample from each of the predictive distributions of e0 and
prevalence projections is first produced. Then a sample vector of age-specific mortality
rates is produced conditionally on the simulated values of e0 and HIV prevalence using
Eq. 2.
2.4 Making full probabilistic population projections
We modified the bayesPop software (Sˇevcˇ´ıkova´ et al. 2016b), which combines the fertility
and mortality projections using the cohort component method, to make full population
projections. The software uses the method described by Raftery et al. (2012) to produce
mortality projections, so the package functions were altered to include the mortality
methodology described above.
3 Results
We discuss results here for four countries: Botswana, Zimbabwe, Mozambique and Sierra
Leone. These countries were chosen to represent different levels of current HIV prevalence.
Botswana and Zimbabwe represent the largest historical epidemics with peak HIV preva-
lences of roughly 25%; Mozambique represents a smaller but still substantial epidemic
(peak HIV prevalence ≈ 11%); while Sierra Leone has a small generalized epidemic (peak
HIV prevalence ≈ 1.6%). Results for Botswana are shown in Figure 2, while results for
the other three countries are in Figs. S1-S3 in Supplemental Materials.
2As described above, HIV MLT itself is deterministic (i.e. for a given e0 and prevalence, HIV MLT
will produce a specific set of mortality rates), but in validation experiments we found that prediction
intervals (derived after running the probabilistic e0 and prevalence projections through HIV MLT) with
the deterministic form occasionally did not cover mortality rates at the oldest ages. To increase coverage,
we add noise from the error term by randomly sampling from a normal distribution for each age with
parameters mean=0 and standard deviation estimated from the distribution of residuals at each age.
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Figure 2a (top left panel) plots the total population projection for Botswana. We
project an increase in total population until about 2065 when the total population begins
to decline (median trajectory). Also in Figure 2a note the increasing width of the predic-
tion intervals as the projection reaches farther into the future reflecting the increase in
uncertainty, a feature of the projection for all countries. WPP 2015 (solid blue line) also
shows sustained population growth followed by a mild reversal in that trend toward the
end of the projection period, but our median projection predicts fewer people in the total
population over the entire projection horizon compared to WPP 2015.
The differences between the WPP projections and ours result mainly from our treat-
ment of mortality, which depends on projections of HIV prevalence and life expectancy.
Botswana has one of the largest HIV epidemics in the world in terms of prevalence. Figure
3 shows the probabilistic projection of HIV prevalence and life expectancy at birth for
Botswana 2015-2100. HIV prevalence in Botswana is projected to remain high, dropping
from a current level of about 25% to roughly 13% by 2050 in the median projection.
Although declining, these high prevalence rates result in relatively low female life ex-
pectancies as modeled with Eq. 1, reaching just above 70 years by 2050, up from less
than 50 years in 2005. Compared to the WPP 2015 projected life expectancy, our median
projection shows sustained lower life expectancy with an increasing gap over the entire
projection period.
Figure 4 shows the difference between our median projection of the total population
and the WPP 2015 projection of total population as a proportion of the WPP 2015
estimate from 2015-2100 for each of the 40 countries with generalized epidemics. By
2050, Botswana has one of the largest differences from WPP 2015 with about 7% fewer
people in the total population compared to the WPP 2015 Revision. In addition to
projecting lower female life expectancy than WPP 2015 (see Figure 3a), our method also
produces relatively high age-specific mortality rates at ages 25-45, consistent with the
mortality generated under high HIV prevalence. This decline in projected total population
is evidence of the crucial role age-specific mortality rates play in shaping future population
makeup in countries with generalized HIV epidemics. Sustained high mortality during the
reproductive years for women compared to WPP 2015 results in fewer women alive during
the reproductive years and thus fewer births compared to WPP 2015.
These effects can be seen in Figs. 2b-2d. Figure 2c shows the probabilistic population
projection for women aged 15-49. We project a decline in the number of women in this
age category beginning around 2055, and Figure 2b shows a shrinking population under
age five over the entire projection period. The effect of high mortality in the reproductive
adult years on future population size, especially for women, reverberates for a number
of years as smaller cohorts are born in each projected period, resulting in smaller total
population compared to WPP 2015. Combined with declining fertility, the effect of high
adult mortality yields an eventual reversal in population growth for Botswana.
Similar conditions exist for some of the other countries with large negative proportional
differences at 2050 (e.g. Zimbabwe, Botswana, Namibia, Central African Republic–all
with differences of greater than five percent at 2050) shown in Figure 4. These coun-
tries typically have large scale HIV epidemics (> 10% prevalence) and our median life
expectancy projection is lower than that for WPP 2015, reducing the number of women
of reproductive age resulting in smaller birth cohorts. Zimbabwe, for example, is pro-
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Figure 2 Probabilistic population projections for Botswana 2015-2100. Past, observed
data: black circles; median probabilistic projection: solid red line, 80% predictive interval:
dashed red lines; 95% predictive interval: dotted red lines; WPP 2015 projection: solid
blue line.
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(b) Probabilistic HIV Prevalence Projection
Figure 3 Probabilistic life expectancy and HIV prevalence projections for Botswana
2015-2100. median of probabilistic projection: solid, red line; 80% predictive interval:
dashed, red line; 95% predictive interval: dotted, red line; WPP 2015 projection: solid,
blue line; observed: black circles. The gray lines in these figures are a random sample of
ten trajectories from the final sample of 1,000 trajectories from the posterior distribution.
jected to have about 13.7% fewer people in the total population in 2050 compared to
the WPP 2015 Revision. HIV prevalence is also projected to decline from about 14%
to 10% between 2015 and 2050. We project higher probabilities of death for women of
reproductive age compared to WPP 2015 (Figure S1d) over the entire projection period
resulting in a likely decreasing number of women of reproductive age past 2050 (Figure
S1c) and consequently smaller birth cohorts over the projection horizon (Figure S1b).
For countries with smaller HIV epidemics, the reduction in the number of women
of reproductive age is less severe and the difference between our projections and WPP
2015 tends to be smaller. Mozambique is projected to have approximately 7% prevalence
(median projection) by 2050, down from around 11% in 2015. Figure S2a shows that
our median projection of the total population is similar to the WPP 2015 projection over
the entire projection period. Theses smaller differences between our projections and the
WPP 2015 projections can also be seen in Figs. S2b and S2c showing the population
projections for under age five and women age 15-49 respectively.
Some countries see larger populations at 2050 in our projection compared to WPP
2015. For Sierra Leone, where HIV prevalence is projected to decrease from about 1.5%
in 2015 to less than 1% by 2050, the difference fromWPP 2015 is in the opposite direction.
We project about 11.5% more people in the total population by 2050 compared to WPP
2015. The much lower rates of HIV prevalence have a far less extreme depressing effect
on total population in Sierra Leone in the long run as evidenced by Figs. S3b and S3c. In
addition to relatively little effect from HIV on the age-specific mortality rates, compared
to WPP 2015, we project consistently higher life expectancy over the projection period for
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Figure 4 Comparison between our median total population projection and WPP 2015
median projection for total population. Each line shows the percentage difference from
the WPP 2015 total population estimate for each country and the solid black line shows
the difference at each period for all countries combined.
Sierra Leone, which is consistent with the life expectancy projection for other countries
for which our method projects higher populations than does WPP 2015 (e.g. Djibouti,
Ethiopia, Guinea Bissau, Jamaica, Nigeria, Sierra Leone; see Figure 4).
Figure 5 plots the probabilistic projections of female life expectancy for six countries
with positive differences in projected population at 2050 as shown in Figure 4. Figure
5 also depicts the WPP 2015 female life expectancy projections for these countries. As
this figure shows, a large portion of the difference between the WPP 2015 total popu-
lation projections and our median projections for these countries arises from differences
in the projections of life expectancy, since these countries have comparatively small HIV
epidemics, which will limit the influence of prevalence on the age pattern of mortality
rates.
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(f) Sierra Leone
Figure 5 Probabilistic life expectancy projections for six countries 2010-2100. median
of probabilistic projection: solid, red line; 80% predictive interval: dashed, red line; 95%
predictive interval: dotted, red line; WPP 2015 projection: solid, blue line; observed:
black circles. The gray lines in these figures are a random sample of ten trajectories from
the final sample of 1,000 trajectories from the posterior distribution.
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4 Validation
4.1 Out-of-sample validation
To validate our method, we calibrated the e0 projection and HIV MLT models with five-
year data from the WPP 2015 revision up to 2010 and used those models to generate
a population projection for the 2010-2015 period for each of the 40 countries. We then
compare the resulting mortality and population distributions with the observations from
WPP 2015 for 2010-2015.
Because our method addresses the mortality component of the projection, we first
assess the accuracy of the mortality predictions for 2010-2015 by calculating the mean
absolute error (MAE) of our median projection for 2010-2015, treating the WPP 2015
estimate as the observed value, for four mortality indicators: e0 (life expectancy at birth),
5q0 (the probability a newborn will die before reaching age five), 45q15 (the probability that
a 15-year-old will die before reaching age 60), and 35q10 (the probability that a 10-year-old
will die before age 45). Table 1 presents the MAE by sex for the four mortality indicators.
For males, the mean absolute error for life expectancy is about 2.3 years, while the MAE
for e0 for females is slightly higher at 2.5 years, suggesting a good fit for the level of
mortality. For the other three indicators, the MAE is less than 4 per 1000 for both males
and females.3 Overall, our method predicted the WPP 2015 estimate for 2010-2015 well
for most countries.
Table 1 Mean absolute error for four mortality indicators for the 2010-2015 out-of-sample
period (5q0, 45q15 and 35q10, all x1000) using our method for projecting HIV prevalence
and life expectancy and using the HIV MLT model for converting to age-specific mortality
rates. All models have been calibrated with data up to 2010 and used to predict the out-
of-sample period 2010-2015.
Mean Absolute Error
e0 5q0 45q15 35q10
Male 2.3 16.3 31.9 22.9
Female 2.5 13.9 33.4 30.6
We further assess the accuracy of our method for projecting age-specific mortality
rates by calculating the proportion of age-specific mortality rates for 2010-2015 (observed
data that were left out for calibration) captured in the 80%, 90%, and 95% predictive
intervals (PI) for 2010-2015 produced with our method. If the method is doing well, we
should capture about the same percentage of the out-of-sample mortality rates as defines
our predictive intervals. The top two rows of Table 2 show the coverage (percentage of
WPP 2015 mortality rates across all ages and all 40 countries captured by the various
interval widths) for the 2010-2015 period. For each PI, our method captures just under
the expected proportion, indicating that the method provides reasonably well calibrated
projections for the out-of-sample period. The third row of table 1 gives the coverage for
3Figure S4 plots the predicted distribution of these three indicators for 2010-2015 along with the WPP
2015 estimate for the same period. This figure lends context to the magnitude of the MAEs in table 1.
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the single quantity of female life expectancy in the out-of-sample period (i.e. the percent-
age of countries whose PIs captured the WPP 2015 estimate for female life expectancy).
Coverage for female life expectancy is also good with our method again capturing approx-
imately the expected proportion of predicted out-of-sample life expectancies.
Table 2 Coverage of WPP 2015 sex-age-specific mortality rates, female life expectancy
at birth, and total population in the 80%, 90%, and 95% PIs for the 2010-2015 out-of-
sample period using our method for projecting HIV prevalence and life expectancy and
using the HIV MLT model for converting to age-specific mortality rates. Fertility and
migration were projected using the bayesPop software. Data from 1970-2010 were used
for calibration, and the resulting estimated model was used to predict the out-of-sample
period 2010-2015.
80% PI 90% PI 95% PI
mx, Male 75 82 88
mx, Female 69 81 86
e0, Female 75 88 90
Total Population 97 97 100
Finally, we calculate coverage similar to that of mortality and life expectancy but for
the total population prediction at 2010-2015.4 The bottom row of Table 2 shows the
percentage of WPP 2015 total population estimates for 2010-2015 captured in the 80%,
90%, and 95% predictive intervals. While the coverages for the mortality rates were not
markedly different from the nominal coverages of the PIs, coverage of the single total
population estimate is near universal (i.e. the observed total population estimate for the
out-of-sample period 2010-2015 was within the 80% and 90% PI for all but one country,
Swaziland, and within the 95% PI for all countries).
4.2 Comparison to Spectrum/EPP
Spectrum/EPP (Futures Institute 2016; Stanecki et al. 2012; Stover et al. 2012) provides
useful information to UNAIDS about high-HIV prevalence countries including estimates
of HIV prevalence, total population, life expectancy, and a host of other demographic and
epidemiological variables in the short term (five years). However, it is, of necessity, quite
complex. We propose a simpler method to project over a longer projection horizon, but
it is instructive to compare our projection results to those obtained from Spectrum in the
near term.
Table 3 shows the mean difference (MD) between our median projection using the
full dataset for calibration (i.e. no out-of-sample period was removed) and Spectrum
among all 40 countries for prevalence and life expectancy at birth for the first three
projection periods.5 For prevalence, our projections differed from Spectrum by less than
4Calculation of total population includes running fertility projections for the out-of-sample period
2010-2015 with the bayesTFR software.
5All Spectrum results were obtained with Spectrum version 5.441 downloaded July 2016
(Futures Institute 2016).
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one percentage point on average across the 40 countries during each of the first three
projection periods, which is substantially less than the prediction margin of error. The
mean differences for life expectancy show that on average across the 40 countries our
projection is between one and two years lower than the Spectrum projection in the very
near term. Thus, overall our projections are similar to those of Spectrum, but using a
much simpler model.
Table 3 Mean difference (MD) for prevalence and life expectancy and mean proportional
difference (MPD) for total population, population aged 0-4, and female population aged
15-49, between our method and the Spectrum/EPP software for the first three projection
periods. All results for Spectrum derived from the Spectrum software version 5.441.
MDa MPDb (%)
Prevalence e0 Total Pop. Total Pop 0-4 Female Pop. 15-49
2015-2020 0.7 -1.76 -0.9 -0.8 -0.2
2020-2025 0.8 -1.10 -1.3 -1.0 -0.3
2025-2030 0.9 -0.97 -1.6 -1.2 -0.3
a Mean Difference between our estimate and that of the Spectrum software
for all 40 countries. These numbers are on the scale of prevalence (percentage
points) and life expectancy (years).
b Mean Proportional Difference is the difference between our median estimate
and the Spectrum estimate as a proportion of the Spectrum estimate. Vary-
ing absolute population sizes among the 40 countries necessitate taking the
proportional error. MPD is in units of per 100.
The right three columns of Table 3 show the mean proportional difference (MPD)
between our median projection and Spectrum for three population quantities: the total
population across all ages, the total population aged 0-4, and the female population aged
15-49. The MPD is the average difference between our median estimate and Spectrum
as a proportion of the Spectrum estimate for a given population indicator (results in
Table 3 for MPD shown as percentages). Again, we present a simpler method but it
should approximate Spectrum at least in the short run. For total population, our median
estimates of total population were about one percent lower than the Spectrum estimate
for the most recent projection period, 2015-2020. The MPD is between one and two
percent for each of the next two periods. Our projections of the population aged 0-
4 are also lower than the Spectrum result by roughly one percent. Finally, our short
term projection results for the female reproductive age population are also close to the
Spectrum result with less than one percent average proportional difference over all three
periods. In sum, results from Table 3 suggest our less complex method approximates the
short-term projections of Spectrum for these demographic quantities reasonably closely.
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5 Discussion
We have presented a method for making probabilistic population projections for coun-
tries with generalized HIV epidemics. We accomplish this by following the Bayesian
probabilistic projection method described by Raftery et al. (2012) for fertility and the
international migration assumptions of the UNPD, but because of the singular nature of
mortality in generalized HIV epidemics, we modify the mortality component of the pro-
jection to incorporate the future trajectory of the epidemic in terms of HIV prevalence
and ART coverage. The probabilistic fertility and mortality projections and the UNPD’s
assumptions about future migration are combined using the cohort component method of
projection. These projections are potentially useful to researchers and policy makers as
this method provides a predictive distribution for population quantities of interest such
as total population, life expectancy, and support ratios into the future. Our method takes
into account uncertainty about future levels of mortality and fertility, the major drivers
of population change, as well as uncertainty about the trajectory of HIV prevalence.
Our approach is less complex than the UNPD’s current method for projecting mortality
in high-HIV prevalence settings and better captures the age pattern of mortality rates
during a generalized HIV epidemic.
Results from the projections described here show that by 2050 and beyond, we project
smaller total populations for about half of the 40 countries under study here compared to
WPP 2015. Many of the countries with the largest negative differences in projected total
population compared to WPP 2015 have large scale HIV epidemics. For these countries,
we tend to project lower total life expectancy over the course of the projection period.
Combined with projected high HIV prevalence, the lower life expectancies result in high
age-specific mortality rates during the younger adult years, and thus fewer women of
reproductive age and consequently smaller birth cohorts. Projected into the future, these
trends lead to smaller total population projections compared to WPP 2015. Coupled with
declining fertility, high mortality rates resulting from HIV/AIDS-related deaths produce
a reversal in population growth by 2100 for some countries with very large epidemics.
Overall, these trends amount to a -1.7% difference in total population amongst all 40
countries by 2100 compared to WPP 2015, a difference of approximately 52.5 million
people.
Although the method presented here for mortality and elsewhere for fertility takes
into account uncertainty about future levels of fertility and mortality, it does not include
uncertainty about international migration in the future, which can be an important source
of forecast errors. Likewise, the life expectancy projection model and the model used to
convert e0 projections to age-specific mortality rates are calibrated with results fromWPP
2015, some of which are themselves modeled, so they reproduce only the variability in the
quantities of interest contained in the WPP results. To the extent that the WPP 2015
data and results used to calibrate these models reflect the empirical reality, the models
we present here should as well. Finally, as in Raftery et al. (2012), this method does not
take into account random variation in the number of births or deaths, given the fertility
and mortality rates.
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Figure S 1 Probabilistic population projections for Zimbabwe 2015-2100. Observed
data: black circles; median probabilistic projection: solid red line, 80% predictive interval:
dashed red lines; 95% predictive interval: dotted red lines; WPP 2015 projection: solid
blue line.
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(d) Projection of female 35q10
Figure S 2 Probabilistic population projections for Mozambique 2015-2100. Observed
data: black circles; median probabilistic projection: solid red line, 80% predictive interval:
dashed red lines; 95% predictive interval: dotted red lines; WPP 2015 projection: solid
blue line.
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(d) Projection of female 35q10
Figure S 3 Probabilistic population projections for Sierra Leone 2015-2100. Observed
data: black circles; median probabilistic projection: solid red line, 80% predictive interval:
dashed red lines; 95% predictive interval: dotted red lines; WPP 2015 projection: solid
blue line.
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